Key points are not available for this paper at this time.
LVI provided a strong predictor of outcome in patients with invasive breast cancer and should be incorporated into breast cancer staging systems.
Share your take
Add a clinician perspective alongside expert commentary.
Rakha et al. (2011) studied this question.